// App-Quantinova.ai

e13594 : Patient compliance to oral anticancer chemotherapy evaluated in breast and colorectal cancer patients receiving capecitabine: The OCTO study.

Researchers

Presenter

  • Emilie Henin

Principal Investigators

  • Aurelie Bourmaud

  • Olivier Colomban

  • Gilles Freyer

  • Michel Tod

  • Catherine Rioufol

  • Veronique N. Trillet-Lenoir

  • Verane Schwiertz

  • Veronique Regnier

  • Benoit You

  • Florence Ranchon

  • Jerome Guitton

  • Raymonde Maraval-Gaget

  • Pascal Girard

  • Franck Chauvin

Medical Centers

  • Institut de Cancerologie Lucien Neuwirth, Saint-Priest en Jarez cedex, France.

  • Universite Lyon 1 - EMR3738, Oullins, France

  • France, Pierre-Benite, France

  • Hospices Civils de Lyon, Lyon, France

  • GINECO & Centre Hospitalier Lyon-Sud, Lyon, France

  • Centre Hospitalier Lyon-Sud, Pierre-Benite, France

  • EMR 3738, Ciblage Therapeutique en Oncologie, Faculte de Medecine et de Maieutique Lyon-Sud Charles Merieux, Universite Claude Bernard Lyon1, Oullins, France

  • Hospices Civils De Lyon, Pierre Benite, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Capecitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved